Literature DB >> 8654373

Selective interaction of JNK protein kinase isoforms with transcription factors.

S Gupta1, T Barrett, A J Whitmarsh, J Cavanagh, H K Sluss, B Dérijard, R J Davis.   

Abstract

The JNK protein kinase is a member of the MAP kinase group that is activated in response to dual phosphorylation on threonine and tyrosine. Ten JNK isoforms were identified in human brain by molecular cloning. These protein kinases correspond to alternatively spliced isoforms derived from the JNK1, JNK2 and JNK3 genes. The protein kinase activity of these JNK isoforms was measured using the transcription factors ATF2, Elk-1 and members of the Jun family as substrates. Treatment of cells with interleukin-1 (IL-1) caused activation of the JNK isoforms. This activation was blocked by expression of the MAP kinase phosphatase MKP-1. Comparison of the binding activity of the JNK isoforms demonstrated that the JNK proteins differ in their interaction with ATF2, Elk-1 and Jun transcription factors. Individual members of the JNK group may therefore selectively target specific transcription factors in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8654373      PMCID: PMC450211     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  56 in total

1.  Both Jun and Fos contribute to transcription activation by the heterodimer.

Authors:  S Hirai; B Bourachot; M Yaniv
Journal:  Oncogene       Date:  1990-01       Impact factor: 9.867

2.  cDNA sequence of a growth factor-inducible immediate early gene and characterization of its encoded protein.

Authors:  C H Charles; A S Abler; L F Lau
Journal:  Oncogene       Date:  1992-01       Impact factor: 9.867

Review 3.  jun: oncogene and transcription factor.

Authors:  P K Vogt; T J Bos
Journal:  Adv Cancer Res       Date:  1990       Impact factor: 6.242

4.  jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun.

Authors:  J Schütte; J Viallet; M Nau; S Segal; J Fedorko; J Minna
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

5.  Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun.

Authors:  R Chiu; P Angel; M Karin
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

6.  Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme.

Authors:  S Andersson; D L Davis; H Dahlbäck; H Jörnvall; D W Russell
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

7.  Activation of ternary complex factor Elk-1 by stress-activated protein kinases.

Authors:  H Gille; T Strahl; P E Shaw
Journal:  Curr Biol       Date:  1995-10-01       Impact factor: 10.834

8.  Phosphorylation of c-jun mediated by MAP kinases.

Authors:  B J Pulverer; J M Kyriakis; J Avruch; E Nikolakaki; J R Woodgett
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

9.  Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73.

Authors:  T Smeal; B Binetruy; D A Mercola; M Birrer; M Karin
Journal:  Nature       Date:  1991-12-12       Impact factor: 49.962

10.  Characterization of junD: a new member of the jun proto-oncogene family.

Authors:  S I Hirai; R P Ryseck; F Mechta; R Bravo; M Yaniv
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

View more
  359 in total

1.  Analysis of mitogen-activated protein kinase pathways used by interleukin 1 in tissues in vivo: activation of hepatic c-Jun N-terminal kinases 1 and 2, and mitogen-activated protein kinase kinases 4 and 7.

Authors:  A Finch; W Davis; W G Carter; J Saklatvala
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

2.  Activation of cJUN N-terminal kinase by herpes simplex virus type 1 enhances viral replication.

Authors:  T I McLean; S L Bachenheimer
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

Review 3.  Mitogen-activated protein kinases: specific messages from ubiquitous messengers.

Authors:  H J Schaeffer; M J Weber
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

4.  Synergistic activation of JNK/SAPK by interleukin-1 and platelet-derived growth factor is independent of Rac and Cdc42.

Authors:  W Davis; L R Stephens; P T Hawkins; J Saklatvala
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

5.  Critical activities of Rac1 and Cdc42Hs in skeletal myogenesis: antagonistic effects of JNK and p38 pathways.

Authors:  M Meriane; P Roux; M Primig; P Fort; C Gauthier-Rouvière
Journal:  Mol Biol Cell       Date:  2000-08       Impact factor: 4.138

6.  TGFbeta and PTHrP control chondrocyte proliferation by activating cyclin D1 expression.

Authors:  F Beier; Z Ali; D Mok; A C Taylor; T Leask; C Albanese; R G Pestell; P LuValle
Journal:  Mol Biol Cell       Date:  2001-12       Impact factor: 4.138

Review 7.  Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets.

Authors:  D W Hommes; M P Peppelenbosch; S J H van Deventer
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

8.  Hippocampal c-Jun-N-terminal kinases serve as negative regulators of associative learning.

Authors:  Tessi Sherrin; Thomas Blank; Cathrin Hippel; Martin Rayner; Roger J Davis; Cedomir Todorovic
Journal:  J Neurosci       Date:  2010-10-06       Impact factor: 6.167

9.  Cell stress-induced phosphorylation of ATF2 and c-Jun transcription factors in rat ventricular myocytes.

Authors:  A Clerk; P H Sugden
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

10.  N-acetyl cysteine mediates protection from 2-hydroxyethyl methacrylate induced apoptosis via nuclear factor kappa B-dependent and independent pathways: potential involvement of JNK.

Authors:  Avina Paranjpe; Nicholas A Cacalano; Wyatt R Hume; Anahid Jewett
Journal:  Toxicol Sci       Date:  2009-01-28       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.